Skip to Main Content
Table 1—

Anthropometric and biochemical variables of the study subjects

Nondiabetic subjectsDiabetic subjects
n 206 110 
Age (years) 60.9 ± 10.4 55.9 ± 9.6 
BMI (kg/m²) 27.3 ± 3.2 28.6 ± 4.1 
Total cholesterol (mmol/l) 5.3 ± 1.1 5.7 ± 1.4 
LDL cholesterol (mmol/l) 3.6 ± 1.0 3.8 ± 1.1 
HDL cholesterol (mmol/l) 1.1 ± 0.3 1.0 ± 0.4 
VLDL cholesterol (mmol/l)* 0.6 ± 0.4 1.0 ± 1.4 
Triglycerides (mmol/l)* 1.5 ± 0.8 2.3 ± 2.2 
Glucose (mg/dl) 96.6 ± 13.0 159.4 ± 51.0 
Insulin (μU/ml) 21.2 ± 8.0 36.9 ± 26.0 
HOMA-IR 4.9 ± 1.6 13.1 ± 7.9 
Adiponectin (μg/ml)* 5.9 ± 4.4 5.7 ± 4.4 
Nondiabetic subjectsDiabetic subjects
n 206 110 
Age (years) 60.9 ± 10.4 55.9 ± 9.6 
BMI (kg/m²) 27.3 ± 3.2 28.6 ± 4.1 
Total cholesterol (mmol/l) 5.3 ± 1.1 5.7 ± 1.4 
LDL cholesterol (mmol/l) 3.6 ± 1.0 3.8 ± 1.1 
HDL cholesterol (mmol/l) 1.1 ± 0.3 1.0 ± 0.4 
VLDL cholesterol (mmol/l)* 0.6 ± 0.4 1.0 ± 1.4 
Triglycerides (mmol/l)* 1.5 ± 0.8 2.3 ± 2.2 
Glucose (mg/dl) 96.6 ± 13.0 159.4 ± 51.0 
Insulin (μU/ml) 21.2 ± 8.0 36.9 ± 26.0 
HOMA-IR 4.9 ± 1.6 13.1 ± 7.9 
Adiponectin (μg/ml)* 5.9 ± 4.4 5.7 ± 4.4 

Data are means or

*

medians ± SE. Diabetes was defined by history or by a fasting plasma glucose >126 mg/dl.

Subjects not being treated with insulin. HOMA-IR, HOMA of insulin resistance.

Close Modal

or Create an Account

Close Modal
Close Modal